Skip to main content

Seramune Oral

This page contains information on Seramune Oral for veterinary use.
The information provided typically includes the following:
  • Seramune Oral Indications
  • Warnings and cautions for Seramune Oral
  • Direction and dosage information for Seramune Oral

Seramune Oral

This treatment applies to the following species:
Company: Sera

equine IgG

bottle contains one dose of 300mL

administer orally in two even amounts 1-2 hours apart, within first 12 hours of life

● protect from sunlight

● store refrigerated at 2 - 8° C/35 - 46° F; do not freeze

● once opened, use entire contents as directed above.

Seramune Oral Indications

for the treatment of failure of passive transfer in neonatal foals

do not mix with other products, except as specified on the label

with any serum product, adverse reactions may occur; in case of reactions, stop treatment and administer epinephrine

use of serum and plasma products has been associated with hepatitis (Theiler’s Disease)

VLN/PCN 328/3607.01


sera®, po box 15866, shawnee mission, kansas 66285-5866 usa


CPN: 1498001.4

P.O. BOX 15866, SHAWNEE MISSION, KS, 66285-5866
Telephone:   913-541-1307
Toll-Free:   800-552-3984
Fax:   913-541-1712
Every effort has been made to ensure the accuracy of the Seramune Oral information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2021 Animalytix LLC. Updated: 2021-10-04